Evidence map›Paper›PMID 8548869›Full record

ReviewCancer metastasis reviews1995

Growth factor regulation of integrin-mediated cell motility.

K Matsumoto, B L Ziober, C C Yao, R H Kramer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cancer metastasis reviews, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Hepatocyte growth factor/scatter factor-induced intracellular signalling.International journal of experimental pathology · 2000
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

K MatsumotoDepartment of Stomatology, University of California, San Francisco 94143-0512, USA.
B L Ziober
C C Yao
R H Kramer
University of California, San Francisco · US

Funding

Regulation of Survival in Oral Squamous Cell CarcinomaR01DE011436 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, RANDALL H · 1995 to 2008
$2.4M
Regulation of Survival in Head and Neck Cancer ProgressionR56DE011436 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, RANDALL H · 2011 to 2011
$185k
INTEGRIN RECEPTOR FOR LAMININ IN MALIGNANT MELANOMAR01CA051884 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KRAMER, RANDALL H · 1990 to 1994
–
ORAL CANCER--ADHESIVE INTERACTIONS DURING PROGRESSIONR01DE010564 · NIDCR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KRAMER, RANDALL H · 1992 to 1995
–
NCI NIH HHS CA51884NIDCR NIH HHS DE10564NIDCR NIH HHS DE11436
6 · The paper itself

Abstract

Cell motility, a primary component of tumor cell invasion, is a continuum of sequential events in which the cell extends pseudopodia, forms nascent attachments, assembles and contracts the cytoskeleton, and finally, as it translocates forward, disengages distal adhesions. What triggers cells to move? Substratum contact mediated by integrin adhesion receptors is important, but other signals such as chemokinetic factors appear to be required for continued crawling. It is now apparent that integrins do not simply bind cells to matrix in a Velcro-like fashion, but also are potent signaling molecules. Initial engagement of integrins induces their condensation into focal contacts, forming anchors to the extracellular matrix and discrete signal-transducing complexes on the cytoplasmic surface. A number of growth factors, through either autocrine or paracrine pathways, can activate the cellular machinery that mobilizes the cell. Thus, these two classes of receptors--the integrin receptors that bind specific extracellular adhesion molecules, and growth factor receptors that bind their respective ligands--can regulate cell locomotion. Not surprisingly, there is 'cross-talk' between integrin and growth factor receptors that occurs through their common intracellular signaling pathways. In this way, each receptor type can either amplify or attenuate the other's signal and downstream response. An example of growth factor-induced motility is the epithelial-mesenchymal transition induced by hepatocyte growth factor/scatter factor (HGF/SF). When bound to its receptor, the c-met proto-oncogene product, HGF/SF induces a phenotypic conversion that appears to be an important aspect of tumor progression in malignant carcinomas. The motogenic response produced by HGF/SF in carcinoma cells occurs in discrete steps in which integrins and focal adhesion kinase (p125FAK) are first recruited to focal contacts. This is rapidly followed by cell spreading, disruption of focal adhesions and cell-cell contacts, and, finally, cell crawling. The precise mechanism by which growth factors such as HGF/SF and its receptor induce this motogenic response and modulate integrin function has not been clearly defined but appears to involve several signaling pathways. Understanding the process by which growth factor and integrin receptors interact and regulate motility may suggest novel targets for therapeutic intervention.

Indexed as

AnimalsCell MovementExtracellular MatrixGrowth SubstancesHumansIntegrinsNeoplasm InvasivenessProto-Oncogene MasGrowth SubstancesIntegrinsMAS1 protein, humanProto-Oncogene Mas

Identifiers

PMID8548869
OpenAlexW1970101996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.